Advanced Search

Journal Navigation

Journal Home



Contact Us

Table of Contents

Click here to register today!

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Forman, L.
Right arrow Articles by Haydon, G. H.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Graft, Vol. 6, No. 2, 129-135 (2003)
DOI: 10.1177/1522162803256720
© 2003 SAGE Publications

Recurrence of Disease after Liver Transplantation

Lisa Forman

Liver Unit Queen Elizabeth Hospital

Geoffrey H. Haydon, MRCP, MD

Liver Unit Queen Elizabeth Hospital, geoffhay{at}

Recurrent hepatitis B and C is common following liver transplantation. Autoimmune disease manifests as primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis. Metabolic diseases, such as hemochromatosis, Wilson's disease, amyloidosis, and alcoholic liver disease (ALD) also recur. Recurrent malignancy also is reported. Liver transplantation is potentially curative in a subset of patients with hepatocellular carcinoma (HCC) with a small tumor burden. Survival after transplantation is 53%-72% after 1 year and 17%-25% after 5 years. Many cases of cryptogenic cirrhosis are due to clandestine NASH.

Key Words: liver transplantation • cirrhosis • hepatitis

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?